IBIO

Ibio Inc

$2.70

+0.35 (+14.89%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 11.01.2026
$4.77
(+76.56%)
Strong Buy: 0
Buy: 6
Hold: 0
Sell: 0
Strong Sell: 0
Description:
iBio, Inc. is a pioneering biotechnology firm based in New York, dedicated to advancing plant-based biopharmaceutical production. The company offers specialized contract development and manufacturing services for biologics, including vaccines and therapeutics, establishing itself as a key player in both domestic and international markets. With its proprietary technologies, iBio enhances the efficiency and scalability of biologics manufacturing, addressing the increasing demand for sustainable and economically viable solutions in the evolving life sciences sector. Through innovation and strategic partnerships, iBio is positioned to contribute significantly to the future of healthcare.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
11750 SORRENTO VALLEY ROAD, SAN DIEGO, CA, UNITED STATES, 92121
Fiscal year end:
June
Market capitalization:
$60.7 Million
EBITDA:
-$19.7 Million
PERatio:
0.0
EPS:
-1.4
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.149

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-100%
How much will you get:
$1
Prices dates:
31-12-2015: $2,800.00 and 31-12-2025: $1.93